Filing Details
- Accession Number:
- 0001209191-18-050839
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-13 16:17:07
- Reporting Period:
- 2018-09-11
- Accepted Time:
- 2018-09-13 16:17:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Biotime Inc | BTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1325697 | J Deborah Andrews | 1911 Walker Avenue Monrovia CA 91016 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2018-09-11 | 1,604 | $2.35 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Shares | Option to Purchase Common Shares | $2.06 | 2023-06-30 | 40,000 | 40,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $3.15 | 2022-06-30 | 20,000 | 20,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $2.72 | 2021-06-30 | 20,000 | 20,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $3.57 | 2020-06-30 | 20,000 | 20,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $3.11 | 2019-06-30 | 20,000 | 20,000 | Direct | |
| Common Shares | Option to Purchase Common Shares | $2.86 | 2019-04-10 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-06-30 | 40,000 | 40,000 | Direct |
| 2022-06-30 | 20,000 | 20,000 | Direct |
| 2021-06-30 | 20,000 | 20,000 | Direct |
| 2020-06-30 | 20,000 | 20,000 | Direct |
| 2019-06-30 | 20,000 | 20,000 | Direct |
| 2019-04-10 | 20,000 | 20,000 | Direct |
Footnotes
- Will become exercisable on June 30, 2019, based upon continued service on the board of directors.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2017.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
- Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014.
- Became exercisable in four equal quarterly installments after the date of grant on April 11, 2014.
Billionaire Hedge Funds
